EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of a 24-week resistance exercise program on Alzheimer’s disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial

Auswirkungen eines 24-wöchigen Krafttrainings auf Alzheimer-Krankheits-Hirnsignaturen bei kognitiv unauffälligen älteren Erwachsenen: Sekundäranalyse der randomisierten AGUEDA-Studie

Javier Sanchez-Martinez iD, Patricio Solis-Urra iD, Beatriz Fernandez-Gamez iD, Javier Fernández-Ortega iD, Lucía Sánchez-Aranda iD, Kirk I Erickson iD, Francisco B Ortega iD, Irene Esteban-Cornejo iD

Age and Ageing · 04.04.2026 · 55 (4)

DOI: 10.1093/ageing/afag086 ↗

Auf einen Blick

Bei 90 kognitiv unauffälligen älteren Erwachsenen war ein 24-wöchiges Krafttrainingsprogramm mit einer geringeren Dicke/Volumen-Signatur verbunden. Für die GMMD-Signatur zeigte sich kein Effekt.

Fragestellung

Welche Effekte hat ein 24-wöchiges Krafttrainingsprogramm auf AD-spezifische Hirnsignaturen bei kognitiv unauffälligen älteren Erwachsenen?

Methode

Sekundäranalyse einer monozentrischen, zweiarmigen, einfach verblindeten randomisierten kontrollierten Studie mit 90 Teilnehmenden; 3 Sitzungen/Woche à 60 min; MRT zu Baseline und nach der Intervention.

Ergebnisse

RE vs. Kontrollgruppe: Dicke/Volumen-Signatur −0,23 SMD (95 %-KI −0,43 bis −0,02); GMMD-Signatur 0,08 SMD (95 %-KI −0,13 bis 0,29). Bei Aβ-positiven Teilnehmenden stärkerer Effekt auf die Dicke/Volumen-Signatur (−0,64 SMD; 95 %-KI −1,09 bis −0,18).

Schlussfolgerung der Autor:innen

Die Autor:innen schlussfolgern, dass die geringere makrostrukturelle AD-Signatur nach 24 Wochen Krafttraining adaptive statt schädliche Gehirnveränderungen widerspiegeln könnte, besonders bei Aβ-positiven älteren Erwachsenen.

Kernaussagen

  • Dicke/Volumen-Signatur unter Krafttraining reduziert
  • Kein Effekt auf die GMMD-Signatur
  • Zusammenhang mit besserer Exekutivfunktion, besonders bei Aβ-positiven

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Age and Ageing, online erschienen am 12.04.2026. Verfasst von Javier Sanchez-Martinez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada…. Hauptthemen laut MEDLINE: Resistance Training, Alzheimer Disease, Cognition, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI/10.13039/501100011033 and FSE+, Spanish Ministry of Science, Innovation and Universities, National Agency for Research and Development (ANID)/Scholarship Program/DOCTORADO BECAS CHILE/2022.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain imaging markers may help detect early cognitive decline and Alzheimer’s disease (AD). Although exercise-related effects on AD-specific brain signatures remain unclear.

Objective

To examine the effects of a 24-week resistance exercise (RE) program on AD brain signatures in cognitively unimpaired older adults, to explore potential moderators and to assess associations with cognition, including mediation effects.

Methods

This secondary analysis of a single-site, two-arm, single-blinded randomized controlled trial included 90 participants (72 ± 4 years; 58% female) randomly assigned by a blind external researcher to an RE group (3 sessions/week, 60 min/session, n = 46) or a wait-list control group (CG, n = 44). T1- and diffusion-weighted MRI were acquired at baseline and post-intervention. Primary outcomes were thickness/volume and grey matter mean diffusivity (GMMD) signatures, derived from cortical and hippocampal regions. Moderators included age, sex, education, multimorbidity, apolipoprotein E ϵ4 status, amyloid beta (Aβ) status and baseline AD brain signatures. Secondary outcomes included cognitive function. Outcome measures and analyses were conducted by staff blinded to intervention assignment.

Results

Compared with the CG, the RE group showed a reduction in the thickness/volume signature (−0.23 standardized mean difference [SMD]; 95% CI, −0.43 to −0.02), but no effect on the GMMD signature (0.08 SMD; 95% CI, −0.13 to 0.29). Aβ-status moderated the effect, as Aβ-positive participants in the RE group showed a larger reduction in the thickness/volume signature than those in the CG (−0.64 SMD; 95% CI, −1.09 to −0.18), whereas no effect was observed in Aβ-negative participants. Thickness/volume and GMMD reductions were associated with improvements in executive function and attentional/inhibitory control, respectively. Changes in AD signatures did not mediate cognitive outcomes.

Conclusion

Our findings suggest that reductions in the macrostructural AD signature following a 24-week RE program may reflect adaptive, rather than detrimental, brain changes, particularly in Aβ-positive older adults, as these changes were associated with improved executive function.

Trial registration

Registered on Clinicaltrials.gov (Identifier: NCT05186090).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Resistance TrainingAlzheimer DiseaseCognitionBrainHumansFemaleAgedMaleSingle-Blind MethodTime FactorsDiffusion Magnetic Resonance ImagingTreatment OutcomeAmyloid beta-PeptidesCognitive EnhancementAge Factors

Stichwörter der Autor:innen

agingbrain cortical thicknesscognitiondiffusion magnetic resonance imagingexerciseolder people

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain.
  • Neuroscience Institute Orlando, AdventHealth Research Institute, Orlando, FL, USA.
  • Faculty of Education and Social Sciences, Andrés Bello University, Viña del Mar, Valparaíso, Chile.
  • Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.

ORCID-Profile: Javier Sanchez-Martinez, Patricio Solis-Urra, Beatriz Fernandez-Gamez, Javier Fernández-Ortega, Lucía Sánchez-Aranda, Kirk I Erickson, Francisco B Ortega, Irene Esteban-Cornejo

Förderung

  • MCIN/AEI/10.13039/501100011033 and FSE+
  • Spanish Ministry of Science, Innovation and Universities
  • National Agency for Research and Development (ANID)/Scholarship Program/DOCTORADO BECAS CHILE/2022
  • MCIN/AEI/10.13039/501100011033/and 'ESF Investing in your future'
  • MCIN/AEI/10.13039/501100011033/and 'ERDF A way of making Europe'

Zitieren

APA

Sanchez-Martinez, J., Solis-Urra, P., Fernandez-Gamez, B., Fernández-Ortega, J., Sánchez-Aranda, L., Erickson, K. I., Ortega, F. B., & Esteban-Cornejo, I. (2026). Effects of a 24-week resistance exercise program on Alzheimer’s disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial. Age and Ageing, 55(4). https://doi.org/10.1093/ageing/afag086

Vancouver

Sanchez-Martinez J, Solis-Urra P, Fernandez-Gamez B, Fernández-Ortega J, Sánchez-Aranda L, Erickson KI, et al. Effects of a 24-week resistance exercise program on Alzheimer’s disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial. Age and Ageing. 2026;55(4). doi:10.1093/ageing/afag086

BibTeX
@article{SanchezMartinez2026,
  author = {Sanchez-Martinez, Javier and Solis-Urra, Patricio and Fernandez-Gamez, Beatriz and Fernández-Ortega, Javier and Sánchez-Aranda, Lucía and Erickson, Kirk I and Ortega, Francisco B and Esteban-Cornejo, Irene},
  title = {Effects of a 24-week resistance exercise program on Alzheimer’s disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {4},
  doi = {10.1093/ageing/afag086}
}
Kostenlos starten →